Tirzepatide Reduces Progression of Chronic Kidney Disease by 41% Among Patients With Type 2 Diabetes Medicine & Technology Jun 06, 2022 An analysis of a clinical trial showed that the drug tirzepatide slowed the progression of chronic kidney disease in adults with type 2 diabetes with an elevated risk of cardiovascular diseases. Read on to learn more details.
TECH & INNOVATION OpenAI’s Whisper Faces Scrutiny Over Accuracy, Experts Find 'Hallucinated' Text in Transcripts